Syndrome  >>  pioglitazone  >>  Phase 4
Welcome,         Profile    Billing    Logout  

6 Trials

Remove FilterRemove FilterRemove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
pioglitazone / Generic mfg.
COMPLEMENT, NCT00672919: Pioglitazone Study of Triglyceride Changes in Subjects With Type 2 Diabetes After Conversion From Rosiglitazone.

Completed
4
305
US
Pioglitazone, ACTOS®, AD-4833
Takeda
Diabetes Mellitus
08/04
08/04
NCT00494312: Safety Study of Pioglitazone Compared To Glyburide on Liver Function

Completed
4
2120
US
Pioglitazone, Actos, AD-4833, Glyburide
Takeda
Diabetes Mellitus, Liver
06/05
06/05
NCT00754403: Efficacy of Pioglitazone and Fortamet Combination Therapy in Subjects With Type 2 Diabetes

Completed
4
312
US
Pioglitazone and metformin, Actos, AD-4833XT, Fortamet, Metformin
Takeda
Diabetes Mellitus
10/06
10/06
NCT00708175: Efficacy of Pioglitazone on Bone Metabolism in Postmenopausal Women With Impaired Fasting Glucose.

Completed
4
156
US
Pioglitazone, ACTOS®, Placebo
Takeda
Bone Metabolism
01/11
02/11
SPLENDOR, NCT00770835 / 2007-003077-44: Efficacy and Safety of Pioglitazone in Treating Subjects With Vascular Complications Associated With Type 2 Diabetes Mellitus.

Checkmark ADA 2013
Jun 2013 - Jun 2013: ADA 2013
Completed
4
39
Europe
Pioglitazone and Metformin, ACTOS®, AD-4833, Glibenclamide and Metformin, Diabeta, Glynase, Micronase, Daonil, Semi-Daonil, Euglucon
Takeda
Diabetes Mellitus
05/11
05/11
NCT00835120: Pioglitazone for the Treatment of Bipolar Disorder and Comorbid Metabolic Syndrome or Insulin Resistance

Completed
4
34
US
Pioglitazone, Actos
University Hospitals Cleveland Medical Center, National Alliance for Research on Schizophrenia and Depression, Takeda Pharmaceuticals North America, Inc.
Metabolic Syndrome, Bipolar Depression, Insulin Resistance
04/13
04/13

Download Options